4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Liver Neoplasms

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balliet, RM; Chen, G; Dellinger, RW; Lazarus, P	1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Liver Neoplasms

Article	Year
UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:3 Topics: Caco-2 Cells; Carcinogens; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Gene Frequency; Genes, Reporter; Genetic Association Studies; Genetic Predisposition to Disease; Genomic Structural Variation; Glucuronosyltransferase; Humans; Isoenzymes; Liver Neoplasms; Metabolic Detoxication, Phase II; Minor Histocompatibility Antigens; Nitrosamines; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Sequence Deletion	2010

Article

Year

UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.

Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:3

Topics: Caco-2 Cells; Carcinogens; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Gene Frequency; Genes, Reporter; Genetic Association Studies; Genetic Predisposition to Disease; Genomic Structural Variation; Glucuronosyltransferase; Humans; Isoenzymes; Liver Neoplasms; Metabolic Detoxication, Phase II; Minor Histocompatibility Antigens; Nitrosamines; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Sequence Deletion

2010